Ian Duncan, PhD
Articles
September 1st 2023
Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes
David Kerr, MBChB, DM Ian Duncan, PhD Enrico Repetto, MD Rana Maroun, PharmD, PhD Alexander Wu, MSc Christopher Perkins, MS Gert Bergman, PhD, MSc Francesco Giorgino, MD, PhD
Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.
May 28th 2021
Population-Based Return on Investment of Deploying Transient Elastography
Mazen Noureddin, MD Andrew Mackenzie, BS Elaine Zhao, BS Scott C. Howell, DO Michael Tunkelrott, MBA Ian Duncan, PhD
Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 16th 2024 | Updated: September 18th 2024
Healing Wounds Through Peer Support
Published: September 3rd 2024 | Updated: September 18th 2024
Dr JT Lew Explores the Barriers to MS Medication Access
Published: August 6th 2024 | Updated: September 18th 2024
Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden
Published: August 16th 2024 | Updated: September 18th 2024
How Can We Improve Obesity Care in 2024 and Beyond?
Published: September 12th 2024 | Updated: September 18th 2024
The American Journal of Managed Care® Announces Lisa Rotenstein, M.D., MBA, as the Recipient of the Seema S. Sonnad Emerging Leader in Managed Care Research Award
